TY - JOUR
T1 - Sjögren-Larsson syndrome
T2 - Anesthetic considerations and practical recommendations
AU - Franzen, Marcellene H.
AU - LeRiger, Michelle M.
AU - Pellegrino, Kaitlyn P.
AU - Kugler, Jane A.
AU - Rizzo, William B.
N1 - Funding Information:
This work was supported by the Sterol and Isoprenoid Research Consortium of the Rare Disease Clinical Research Network grant U54 HD061939 from the Eunice Kennedy Shriver National Institutes of Child Health & Human Development and National Center for Advancing Translational Sciences, NIH.
Publisher Copyright:
© 2020 John Wiley & Sons Ltd
PY - 2020/12
Y1 - 2020/12
N2 - Background: Sjögren-Larsson syndrome is a rare inherited neurocutaneous disorder characterized by congenital ichthyosis, spasticity, intellectual disability, seizures, and ophthalmologic changes. Most individuals with Sjögren-Larsson syndrome live well into adulthood and often require surgical intervention to manage their symptomatology. Aims: The aim of this work was to review the clinical aspects of Sjögren-Larsson syndrome, highlight the unique anesthetic considerations associated with this disease, and provide practical recommendations about anesthetic management. Methods: A retrospective case review from February 2013 to October 2019 was performed based on subject participation in a Sjögren-Larsson syndrome longitudinal study at the University of Nebraska Medical Center. Anesthetic and surgical records were reviewed for the following data: age, sex, relevant comorbid conditions, anesthetic induction and maintenance agents, intravenous and oral analgesics, muscle relaxants, and anesthetic-related complications. Results: Fourteen patients with Sjögren-Larsson syndrome undergoing 48 anesthetic events were identified. A variety of anesthetic techniques was utilized. No serious adverse events were encountered. The most common clinical observations were related to the ichthyosis seen in Sjögren-Larsson syndrome, which led to difficulty in adherence of electrocardiogram leads and intravenous catheter dressings. Conclusions: We found that anesthesia can be safely administered in patients with Sjögren-Larsson syndrome. Providers should be aware of anesthetic management issues in Sjögren-Larsson syndrome including challenges placing and securing lines and monitors secondary to the ichthyosis.
AB - Background: Sjögren-Larsson syndrome is a rare inherited neurocutaneous disorder characterized by congenital ichthyosis, spasticity, intellectual disability, seizures, and ophthalmologic changes. Most individuals with Sjögren-Larsson syndrome live well into adulthood and often require surgical intervention to manage their symptomatology. Aims: The aim of this work was to review the clinical aspects of Sjögren-Larsson syndrome, highlight the unique anesthetic considerations associated with this disease, and provide practical recommendations about anesthetic management. Methods: A retrospective case review from February 2013 to October 2019 was performed based on subject participation in a Sjögren-Larsson syndrome longitudinal study at the University of Nebraska Medical Center. Anesthetic and surgical records were reviewed for the following data: age, sex, relevant comorbid conditions, anesthetic induction and maintenance agents, intravenous and oral analgesics, muscle relaxants, and anesthetic-related complications. Results: Fourteen patients with Sjögren-Larsson syndrome undergoing 48 anesthetic events were identified. A variety of anesthetic techniques was utilized. No serious adverse events were encountered. The most common clinical observations were related to the ichthyosis seen in Sjögren-Larsson syndrome, which led to difficulty in adherence of electrocardiogram leads and intravenous catheter dressings. Conclusions: We found that anesthesia can be safely administered in patients with Sjögren-Larsson syndrome. Providers should be aware of anesthetic management issues in Sjögren-Larsson syndrome including challenges placing and securing lines and monitors secondary to the ichthyosis.
KW - Sjögren-Larsson syndrome
KW - anesthesia
KW - fatty aldehyde dehydrogenase
KW - ichthyosis
KW - intellectual disability
KW - spasticity
UR - http://www.scopus.com/inward/record.url?scp=85093864263&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85093864263&partnerID=8YFLogxK
U2 - 10.1111/pan.14034
DO - 10.1111/pan.14034
M3 - Article
C2 - 33037729
AN - SCOPUS:85093864263
SN - 1155-5645
VL - 30
SP - 1390
EP - 1395
JO - Paediatric Anaesthesia
JF - Paediatric Anaesthesia
IS - 12
ER -